Prolight Diagnostics AB (publ) (NGM:PRLD)

Sweden flag Sweden · Delayed Price · Currency is SEK
18.28
+0.98 (5.66%)
At close: Feb 27, 2026
-60.00%
Market Cap 220.18M
Revenue (ttm) 42.20M
Net Income (ttm) -49.71M
Shares Out 12.04M
EPS (ttm) -4.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,431
Average Volume 12,673
Open n/a
Previous Close 17.30
Day's Range n/a
52-Week Range 17.00 - 80.92
Beta 3.19
RSI 47.37
Earnings Date Feb 25, 2026

About Prolight Diagnostics AB

Prolight Diagnostics AB (publ) develops diagnostic systems used in point of care testing systems in Sweden. The company offers Psyros, for measurement of biomarkers at extremely low concentrations; and MicroFlex, a point of care system to test with a small disposable cartridge. Prolight Diagnostics AB (publ) was incorporated in 1999 and is based in Lund, Sweden. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1999
Employees 21
Stock Exchange Nordic Growth Market
Ticker Symbol PRLD
Full Company Profile

Financial Performance

In 2025, Prolight Diagnostics AB's revenue was 42.20 million, an increase of 16.18% compared to the previous year's 36.33 million. Losses were -49.71 million, 84.5% more than in 2024.

Financial Statements

News

There is no news available yet.